Population
77 African-American subjects, comprising 35 obese patients with diabetic ketoacidosis, 22 obese patients…
Design
Cohort
Follow-up
12 weeks
Authors
Loading...
May support insulin discontinuation after acute DKA in obese patients; leaves open confirmation of a distinct T2D subset.
Obese African-American patients presenting with DKA often have preserved beta-cell function and represent a subset of type II diabetes, as many can discontinue insulin therapy after the acute episode resolves.
Umpierrez et al. (1995) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: